https://www.selleckchem.com/pr....oducts/talabostat.ht
01), with no statistically significant differences in distress. Conclusion The findings suggest that the QPL is feasible, acceptable, can improve knowledge and decrease decisional conflict in the large group of women deciding treatment while integrating RS test results.Purpose The Edmonton Symptom Assessment System (ESAS) is a validated instrument whose use has been standardized in the Ontario cancer system to measure symptoms among ambulatory patients with cancer. The objective was to examine the effect of ESAS exposure on visits to
Like
Comment
Share
